How to buy RTI Surgical stock (RTIX)

RTI Surgical is a medical devices business based in the US. RTI Surgical shares (RTIX) are listed on the NASDAQ and all prices are listed in US Dollars. RTI Surgical employs 935 staff and has a trailing 12-month revenue of around $284.8 million.

Our top picks for where to buy RTI Surgical stock

Buy RTI Surgical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

RTI Surgical stock price (NASDAQ: RTIX)

Use our graph to track the performance of RTIX stocks over time.

RTI Surgical shares at a glance

• Key figures

Information last updated 2021-01-28.

52-week range	$0.00 - $0.00
50-day moving average more info button	$2.25
200-day moving average more info button	$2.29
Wall St. target price	$5.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.05

Is it a good time to buy RTI Surgical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is RTI Surgical stock undervalued or overvalued?

Valuing RTI Surgical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of RTI Surgical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

RTI Surgical's PEG ratio

RTI Surgical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.39. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into RTI Surgical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

RTI Surgical's EBITDA

RTI Surgical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $13.7 million.

The EBITDA is a measure of a RTI Surgical's overall financial performance and is widely used to measure a its profitability.

RTI Surgical financials

Revenue TTM	$284.8 million
Gross profit TTM	$174.7 million
Return on assets TTM	-3.42%
Return on equity TTM	0%
Profit margin	-90.98%
Book value	$0.23
Market Capitalization more info button	$234.2 million

TTM: trailing 12 months

RTI Surgical share dividends

We're not expecting RTI Surgical to pay a dividend over the next 12 months.

RTI Surgical share price volatility

Over the last 12 months, RTI Surgical's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while RTI Surgical's is 2.0319. This would suggest that RTI Surgical's shares are significantly more volatile than the average for this exchange and represent a higher risk.

RTI Surgical overview

Surgalign Holdings, Inc. , a medical technology company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It offers coflex interlaminar stabilization device, an implant for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; SImmetry sacroiliac joint fusion system, which decreases in opioid use, pain, and disability; and Fortilink IBF system with TETRAfuse ?3D technology. The company's implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force and various OEM relationships to healthcare providers, hospitals, and other healthcare facilities, as well as through a network of independent distributors. The company was founded in 1997 and is headquartered in Deerfield, Illinois. .

Frequently asked questions

What percentage of RTI Surgical is owned by insiders or institutions?
Currently 11.17% of RTI Surgical shares are held by insiders and 79.575% by institutions. How many people work for RTI Surgical?
Latest data suggests 935 work at RTI Surgical. When does the fiscal year end for RTI Surgical?
RTI Surgical's fiscal year ends in December. Where is RTI Surgical based?
RTI Surgical's address is: 520 Lake Cook Road, Deerfield, IL, United States, 60015 What is RTI Surgical's ISIN number?
RTI Surgical's international securities identification number is: US74975N1054 What is RTI Surgical's CUSIP number?
RTI Surgical's Committee on Uniform Securities Identification Procedures number is: 75886N100